Skip Navigation LinksHome > August 2013 - Volume 32 - Issue 8 > Eye Banking and Corneal Transplantation Communicable Adverse...
Cornea:
doi: 10.1097/ICO.0b013e31828f9d64
Special Article

Eye Banking and Corneal Transplantation Communicable Adverse Incidents: Current Status and Project NOTIFY

Dubord, Paul J. MD*; Evans, G. Dewey PhD; Macsai, Marian S. MD†,‡; Mannis, Mark J. MD, FACS§; Glasser, David B. MD; Strong, Douglas M. PhD; Noël, Luc MD**; Fehily, Deirdre PhD††

Collapse Box

Abstract

Purpose:

Evidence of the transmission of disease via donor ocular tissue has been demonstrated for adenocarcincoma, rabies, hepatitis B virus, cytomegalovirus, herpes simplex virus, Creutzfeldt-Jakob disease, and a variety of bacterial and fungal infections.

Methods:

Although there is no evidence to date of disease transmission for HIV infection, syphilis, hepatitis C, hepatitis A, tuberculosis, HTLV-1 and -2 infection, active leprosy, active typhoid, smallpox, and active malaria, these entities remain contraindications for transplantation for all eye banks nationally and internationally. The potential sources of contamination include infected donors, during the process of removing tissue from cadaveric donors, the processing environment, and contaminated supplies and reagents used during processing. The transmissions of Herpes simplex virus and HSV via corneal graft have been shown to be responsible for primary graft failure. HSV-1 may also be an important cause of PFG.

Results:

The long latency period of some diseases, the emergence of new infectious disease, and the reemergence of others emphasize the need for long-term record maintenance and effective tracing capabilities.

Conclusions:

The standardization of definitions for adverse events and reactions will be necessary to support the prevention and transmission of disease. International classification of a unique identification system for donors will be increasingly important for vigilance and traceability in cross-national exportation of human cells, tissues, and cellular- and tissue-based products. Opportunities for continuous improvement exist as does the need for constant vigilance and surveillance.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.